Annual Flat Fee. The Parties agree to amend Section 3.6 of the MSA with respect to the calendar year 2019 as follows: Subject to the below, Shire International will make an annual lump sum payment of € [*****] ([*****] Euro) to Centogene for the performance of [*****] of Diagnostic Tests for Morbus Fabry, Morbus Gaucher, Morbus Hunter, MPS1, MPS2, MPS3, MPS4, MPS6 and MPS7 in the calendar year 2019 (“Annual Flat Fee”). The financial terms of the Annual Flat Fee as well as other financial assumptions under the MSA and Supply Agreement are set forth in more detail in Appendix 1 to this 2019 Amendment. Centogene hereby expressly waives any payment claims for Excess Diagnostic Tests under Section 3.6(c) of the MSA; provided, however, that only the first [*****] Diagnostic Tests for MPS1, MPS3, MPS4, MPS6 and MPS7 performed in 2019 will be included in the Annual Flat Fee. Any additional Diagnostic Tests for MPS1, MPS3, MPS4, MPS6 and MPS7 will be invoiced and paid in accordance with Sec. 3.6 (c) of the MSA.
Appears in 3 contracts
Samples: Global Master Services Agreement and Supply Agreement (Centogene B.V.), Global Master Services Agreement and Supply Agreement (Centogene B.V.), Global Master Services Agreement and Supply Agreement (Centogene B.V.)
Annual Flat Fee. The Parties agree to amend Section 3.6 of the MSA with respect to the calendar year 2019 years 2017 and 2018 as follows: Subject to the below, Shire International will make an annual lump sum payment of € [*****] ([*****] Euro) to Centogene for the performance of [*****] of Diagnostic Tests for Morbus Fabry, Morbus Gaucher, Morbus Hunter, MPS1, MPS2, MPS3, MPS4, MPS4 and MPS6 and MPS7 in the calendar year 2019 years 2017 and 2018 (“Annual Flat Fee”). The financial terms of the Annual Flat Fee as well as other financial assumptions under the MSA and Supply Agreement are set forth in more detail in Appendix 1 to this 2019 2017 Amendment. Centogene hereby expressly waives any payment claims for Excess Diagnostic Tests under Section 3.6(c) of the MSA; provided, however, that only the first [*****] Diagnostic Tests for MPS1, MPS3, MPS4, MPS4 and MPS6 and MPS7 performed in 2019 each of 2017 and 2018 will be included in the Annual Flat Fee. Any additional Diagnostic Tests for MPS1, MPS3, MPS4, MPS4 and MPS6 and MPS7 will be invoiced and paid in accordance with Sec. 3.6 (c) of the MSA.
Appears in 3 contracts
Samples: Global Master Services Agreement and Supply Agreement (Centogene B.V.), Global Master Services Agreement and Supply Agreement (Centogene B.V.), Global Master Services Agreement and Supply Agreement (Centogene B.V.)
